These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26475878)

  • 21. Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation.
    Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Yoneyama N; Hara K; Nakamura R; Watanabe H; Senda J; Atsuta N; Ito M; Hirayama M; Yamamoto M; Fujimoto Y; Kajita Y; Wakabayashi T; Sobue G
    J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):856-64. PubMed ID: 25280914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe, Symptomatic, Self-limited Unilateral DBS Lead Edema Following Bilateral Subthalamic Nucleus Implantation: Case Report and Review of the Literature.
    Gerard CS; Metman LV; Pal G; Karl J; Sani S
    Neurologist; 2016 Jul; 21(4):58-60. PubMed ID: 27348140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous bilateral stereotactic procedure for deep brain stimulation implants: a significant step for reducing operation time.
    Fonoff ET; Azevedo A; Angelos JS; Martinez RC; Navarro J; Reis PR; Sepulveda ME; Cury RG; Ghilardi MG; Teixeira MJ; Lopez WO
    J Neurosurg; 2016 Jul; 125(1):85-9. PubMed ID: 26684776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.
    De Gaspari D; Siri C; Landi A; Cilia R; Bonetti A; Natuzzi F; Morgante L; Mariani CB; Sganzerla E; Pezzoli G; Antonini A
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):450-3. PubMed ID: 16543520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.
    Timmermann L; Jain R; Chen L; Maarouf M; Barbe MT; Allert N; Brücke T; Kaiser I; Beirer S; Sejio F; Suarez E; Lozano B; Haegelen C; Vérin M; Porta M; Servello D; Gill S; Whone A; Van Dyck N; Alesch F
    Lancet Neurol; 2015 Jul; 14(7):693-701. PubMed ID: 26027940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients.
    Tir M; Devos D; Blond S; Touzet G; Reyns N; Duhamel A; Cottencin O; Dujardin K; Cassim F; Destée A; Defebvre L; Krystkowiak P
    Neurosurgery; 2007 Aug; 61(2):297-304; discussion 304-5. PubMed ID: 17762742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive and psychiatric outcome 3 years after globus pallidus pars interna or subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Boel JA; Odekerken VJ; Schmand BA; Geurtsen GJ; Cath DC; Figee M; van den Munckhof P; de Haan RJ; Schuurman PR; de Bie RM;
    Parkinsonism Relat Disord; 2016 Dec; 33():90-95. PubMed ID: 27688200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggressive behavior as a rare side effect of subthalamic stimulation in Parkinson's disease.
    Papuć E; Trojanowski T; Obszańska K; Stelmasiak Z
    Neurocase; 2015; 21(2):220-5. PubMed ID: 24564255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative symptoms of psychosis after deep brain stimulation in patients with Parkinson's disease.
    Qureshi AA; Cheng JJ; Sunshine AN; Wu A; Pontone GM; Cascella N; Lenz FA; Grill SE; Anderson WS
    Neurosurg Focus; 2015 Jun; 38(6):E5. PubMed ID: 26030705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An update of the impact of deep brain stimulation on non motor symptoms in Parkinson's disease.
    Klingelhoefer L; Samuel M; Chaudhuri KR; Ashkan K
    J Parkinsons Dis; 2014; 4(2):289-300. PubMed ID: 24613865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinsonian gait improves with bilateral subthalamic nucleus deep brain stimulation during cognitive multi-tasking.
    Chenji G; Wright ML; Chou KL; Seidler RD; Patil PG
    Parkinsonism Relat Disord; 2017 May; 38():72-79. PubMed ID: 28258925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of rehabilitation in deep brain stimulation of the subthalamic nucleus for Parkinson's disease: a pilot study.
    Tassorelli C; Buscone S; Sandrini G; Pacchetti C; Furnari A; Zangaglia R; Bartolo M; Nappi G; Martignoni E
    Parkinsonism Relat Disord; 2009 Nov; 15(9):675-81. PubMed ID: 19398215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological crying induced by deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Wolf ME; Abdallat M; Blahak C; Krauss JK
    J Clin Neurosci; 2017 Nov; 45():159-161. PubMed ID: 28887071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive change on the repeatable battery of neuropsychological status (RBANS) in Parkinson's disease with and without bilateral subthalamic nucleus deep brain stimulation surgery.
    Rinehardt E; Duff K; Schoenberg M; Mattingly M; Bharucha K; Scott J
    Clin Neuropsychol; 2010 Nov; 24(8):1339-54. PubMed ID: 20967688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reoperation for suboptimal outcomes after deep brain stimulation surgery.
    Ellis TM; Foote KD; Fernandez HH; Sudhyadhom A; Rodriguez RL; Zeilman P; Jacobson CE; Okun MS
    Neurosurgery; 2008 Oct; 63(4):754-60; discussion 760-1. PubMed ID: 18981887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
    Witt K; Daniels C; Krack P; Volkmann J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    J Neurol Sci; 2011 Nov; 310(1-2):261-6. PubMed ID: 21733529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An investigation into the effects and prognostic factors of cognitive decline following subthalamic nucleus stimulation in patients with Parkinson's disease.
    Nimura T; Nagamatsu KI; Ando T; Matsumoto A; Hisanaga K; Tominaga T
    J Clin Neurosci; 2017 Oct; 44():164-168. PubMed ID: 28676310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep brain stimulation: neuropsychological and neuropsychiatric issues.
    Voon V; Kubu C; Krack P; Houeto JL; Tröster AI
    Mov Disord; 2006 Jun; 21 Suppl 14():S305-27. PubMed ID: 16810676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.